Evidence map›Paper›PMID 24249111›Full record

ArticleThe Journal of experimental medicine2013

IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation.

Jan-Eric Turner, Peter J Morrison, Christoph Wilhelm, Mark Wilson, Helena Ahlfors, Jean-Christophe Renauld, Ulf Panzer, Helena Helmby, Brigitta Stockinger

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 249 papers.

0numbers the graph read from it
0cells of the map it votes in
249citing papers in PubMed
16.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

249 citing papers in PubMed, 390 citations in OpenAlex.

  1. Article
  2. Article
  3. Dynamics of Interleukin-9 Producing Lymphocytes inPathogens (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Group 2 innate lymphoid cells derived IL-9 reduces macrophage apoptosis and attenuates acute lung injury in sepsis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article

189 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Jan-Eric TurnerDivision of Molecular Immunology, Medical Research Council National Institute for Medical Research, London NW7 1AA, England, UK.
Peter J Morrison
Christoph Wilhelm
Mark Wilson
Helena Ahlfors
Jean-Christophe Renauld
Ulf Panzer
Helena Helmby
Brigitta Stockinger
Medical Research Council · GBLudwig Cancer Research · BENational Institute of Allergy and Infectious Diseases · USUniversität Hamburg · DEUniversity Medical Center Hamburg-Eppendorf · DEUniversity of London · GB

Funding

Medical Research Council MC_U117512792Medical Research Council MC_UP_A253_1028Medical Research Council U.117512792
6 · The paper itself

Abstract

IL-9 fate reporter mice established type 2 innate lymphoid cells (ILC2s) as major producers of this cytokine in vivo. Here we focus on the role of IL-9 and ILC2s during the lung stage of infection with Nippostrongylus brasiliensis, which results in substantial tissue damage. IL-9 receptor (IL-9R)-deficient mice displayed reduced numbers of ILC2s in the lung after infection, resulting in impaired IL-5, IL-13, and amphiregulin levels, despite undiminished numbers of Th2 cells. As a consequence, the restoration of tissue integrity and lung function was strongly impaired in the absence of IL-9 signaling. ILC2s, in contrast to Th2 cells, expressed high levels of the IL-9R, and IL-9 signaling was crucial for the survival of activated ILC2s in vitro. Furthermore, ILC2s in the lungs of infected mice required the IL-9R to up-regulate the antiapoptotic protein BCL-3 in vivo. This highlights a unique role for IL-9 as an autocrine amplifier of ILC2 function, promoting tissue repair in the recovery phase after helminth-induced lung inflammation.

Indexed as

AmphiregulinAnimalsApoptosisCell SurvivalCytokinesEGF Family of ProteinsFemaleFlow CytometryGlycoproteinsInflammationIntercellular Signaling Peptides and ProteinsInterleukin-13Interleukin-9LungLung DiseasesLymphocytesAmphiregulinAreg protein, mouseCytokinesEGF Family of ProteinsGlycoproteinsIntercellular Signaling Peptides and ProteinsInterleukin-13Interleukin-9

Identifiers

PMID24249111
PMCPMC3865473
OpenAlexW2096545973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.